流水號
86867
課號
Biot8002
課程識別碼
642 D0030
無分班
- 3 學分
選修
生物科技研究所 / 幹細胞與再生醫學學程
生物科技研究所
幹細胞與再生醫學學程
選修- 林劭品
- 搜尋教師開設的課程
生物資源暨農學院 生物科技研究所
shaupinglin@ntu.edu.tw
- 生農學院 生技 樓 402 室
- I have decided to devote myself in a research carrier in Biological Sciences since I was a high school student. My passion and motivation still holds true. Epigenetics is a fast growing field whose significance has been revealed in various physiological process, as well as disease conditions, including cancer. Studying epigenetic reprogramming mechanism forms the foundation for the possibility of nuclear transfer-based therapeutic cloning, stem cell technology and tissue engineering. Heritable changes not involving mutations have been underestimated, especially in Taiwan. I am now eager to continue and extend my research in this field as well as passing my passion in Epigenetics and as a scientist to a younger generation in Taiwan. I have every belief that we can make a significant contribution in Taiwanese Epigenetic research community together.
- 一 2, 3, 4
生技所415
2 類加選
修課總人數 10 人
本校 10 人
無領域專長
- 英文授課
- 核心能力與課程規劃關聯圖
- 備註本課程以英語授課。與游舒涵合授
- 修課限制
限碩士班以上
本校選課狀況
載入中- 課程概述這門幹細胞生物學課程將為學生提供各種類型乾細胞的概述、幹細胞更新、分化以及體細胞重編程、去分化和轉分化的特性和機制。將重點介紹這些現象背後的表觀遺傳機制以及與早期胚胎髮育和生殖細胞發育的比較。此外,還將介紹幹細胞在藥物篩選平台中的應用、幹細胞和3D類器官培養在細胞治療和藥物篩選平台中的應用。還將介紹將生物材料整合到干細胞研究和治療中的附加價值。台灣和各國目前對細胞療法的監管也將被討論和辯論。除了教學課程和在線補充教材外,還將介紹精選的近期研究文章,並介紹每篇原創研究文章背後的實驗設計。學生將有機會了解“作者和審稿人”對稿件審稿過程的理解。角色扮演活動。還將開發和使用英語的科學口頭和書面表達能力。
- 課程目標幫助學生深入了解幹細胞在發育和治療中的特性和前景。 幫助學生建立足夠的背景來判斷幹細胞相關研究文章的質量。 幫助學生對基於乾細胞的治療和相關行業建立自己的看法。 將幫助學生就乾細胞相關主題進行口頭和書面報告,並用英語進行科學辯論。
- 課程要求
- 預期每週課後學習時數
- Office Hour
- 指定閱讀
- 參考書目
- 評量方式
30% Final Written Report
(In one of the following formats: “News and Views (about original research articles published between 2021 to 2023)”; “Mini-Reviews”; Reviewers' Comments; Proposals
20% Group presentation/ Discussion
Group Mark
20% Homework and Participation in the Discussion Activities
Individual Mark
30% Midterm Exam
Open Book/Internet/Notes…
- 針對學生困難提供學生調整方式
調整方式 說明 上課形式 以錄音輔助
以錄影輔助
提供學生彈性出席課程方式
作業繳交方式 書面報告取代口頭報告
團體報告取代個人報告
考試形式 書面(口頭)報告取代考試
- 課程進度
2022/Sept/5th第 1 週 2022/Sept/5th Introduction of Stem Cells (Managing Instructor/Student expectations; preparing for student grouping) 2022/Sept/12th第 2 週 2022/Sept/12th Significance and Application of Stem Cells in Biology and Medicine 2022/Sept/19th第 3 週 2022/Sept/19th T cell differentiation Also, Sept. 22nd-24th; Asian Cellular Ther-apy Organization (ACTO 2022 confer-ence) https://www.acto2022.org/program.asp 2022/Sept/26th第 4 週 2022/Sept/26th Cell Therapy for Cancer Treatment (Ping can attend online) 2022/Oct/3rd第 5 週 2022/Oct/3rd Dynamics of Epigenomic Modulation in Stem Cell Biology 2022/Oct/10th第 6 週 2022/Oct/10th National Holiday; No class 2022/Oct/17th第 7 週 2022/Oct/17th Instructor guided discussion session 2022/Oct/24th第 8 週 2022/Oct/24th Midterm Exam 2022/Oct/31st 2022/Nov/2nd第 9 週 2022/Oct/31st 2022/Nov/2nd Stem Cell/ Germ Cell/ Epigenomic Workshop Part I Introduction of Prof. Bernhard Payer (Centre for Genomic Regulation; Spain) and Prof. Diana Laird (UCSF, USA) 2022/Nov/7th第 10 週 2022/Nov/7th - 2022 International Congress of Cell Biology and Asian Pacific Organization for Cell Biology (ICCB & APOCB) Joint Meeting, to be held from the 7th to 11th of November, 2022 (https://2022iccb-apocb.cscmb.org.tw/About/about?id=58) - Stem Cell/ Germ Cell/ Epigenomic Workshop Part II (Meeting and discussing with invited international speakers) 2022/Nov/14th第 11 週 2022/Nov/14th Leaded discussion over cancer biology/ cell therapy related topics 2022/Nov/21st第 12 週 2022/Nov/21st Students’ presentation over Prof. Bernhard Payer’s work/field; Other Stem Cell related topics 2022/Nov/28th第 13 週 2022/Nov/28th Students’ presentation over Prof. Diana Laird ‘s work/field; Other Stem Cell related topics 2022/Dec/5th第 14 週 2022/Dec/5th Leaded discussion/presentation on the promise and limitation of cell/extracellular vesicle assisted therapy 2022/Dec/12th第 15 週 2022/Dec/12th Site Visit? Assisted Reproductive Technology (test tube baby) industry 2022/Dec/19th第 16 週 2022/Dec/19th Submission of final written report (Maximum 5 pages excluding Figures